We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.4%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
–
Cap. Flow
+$1.29B
Cap. Flow
% of AUM
101.89%
Top 10 Holdings %
Top 10 Hldgs %
12.2%
Holding
422
New
422
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$18.9M |
| 2 |
AGN
Allergan Inc
AGN
|
+$18.6M |
| 3 |
Pfizer
PFE
|
+$18.6M |
| 4 |
Western Digital
WDC
|
+$15.4M |
| 5 |
SHPG
Shire pic
SHPG
|
+$15.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.26% |
| 2 | Consumer Discretionary | 12.33% |
| 3 | Technology | 11.82% |
| 4 | Industrials | 10.72% |
| 5 | Financials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Westlake Corp
WLK
$8.95B
| $10.7M | 0.85% |
+222,436
| New | +$10M |
|
|
FNSR
27
DELISTED
Finisar Corp
FNSR
| $10.7M | 0.85% |
+632,290
| New | +$8.59M |
|
|
PCH
28
DELISTED
PotlatchDeltic
PCH
| $10.7M | 0.84% |
+263,659
| New | +$12.1M |
|
29
Agilent Technologies
A
$39.5B
| $10.7M | 0.84% |
+348,328
| New | +$10.8M |
|
30
CBRE Group
CBRE
$43B
| $10.4M | 0.82% |
+446,864
| New | +$10.6M |
|
|
TGI
31
DELISTED
Triumph Group
TGI
| $10.4M | 0.82% |
+130,865
| New | +$10.1M |
|
32
Louisiana-Pacific
LPX
$5.15B
| $10.3M | 0.82% |
+699,769
| New | +$12.7M |
|
33
Zoetis
ZTS
$32.3B
| $10.3M | 0.82% |
+334,444
| New | +$10.8M |
|
34
American Eagle Outfitters
AEO
$2.99B
| $10.3M | 0.81% |
+563,026
| New | +$10.8M |
|
35
Quanta Services
PWR
$102B
| $9.94M | 0.78% |
+375,570
| New | +$10.4M |
|
36
Cooper Companies
COO
$14.5B
| $9.86M | 0.78% |
+331,364
| New | +$9.31M |
|
37
Signet Jewelers
SIG
$3.69B
| $9.41M | 0.74% |
+139,629
| New | +$9.53M |
|
38
Thermo Fisher Scientific
TMO
$212B
| $9.41M | 0.74% |
+111,155
| New | +$9.25M |
|
39
Maximus
MMS
$3.27B
| $9.29M | 0.73% |
+249,474
| New | +$9.54M |
|
|
PRE
40
DELISTED
PARTNERRE LTD
PRE
| $9.27M | 0.73% |
+102,372
| New | +$9.31M |
|
|
DFT
41
DELISTED
DuPont Fabros Technology Inc.
DFT
| $9.19M | 0.73% |
+380,662
| New | +$9.52M |
|
|
NFX
42
DELISTED
Newfield Exploration
NFX
| $9.1M | 0.72% |
+380,778
| New | +$8.7M |
|
|
ADT
43
DELISTED
ADT Corp
ADT
| $8.51M | 0.67% |
+213,622
| New | +$9.08M |
|
|
SWI
44
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $8.32M | 0.66% |
+214,457
| New | +$9.83M |
|
|
RDC
45
DELISTED
Rowan Companies Plc
RDC
| $8.16M | 0.64% |
+239,571
| New | +$8.04M |
|
46
Comcast
CMCSA
$87.2B
| $8.09M | 0.64% |
+386,142
| New | +$7.97M |
|
|
ATW
47
DELISTED
Atwood Oceanics
ATW
| $8.02M | 0.63% |
+154,010
| New | +$7.98M |
|
48
Bunge Global
BG
$20.2B
| $7.9M | 0.62% |
+111,573
| New | +$7.85M |
|
49
SLB Ltd
SLB
$73.2B
| $7.82M | 0.62% |
+109,160
| New | +$8.08M |
|
50
Radian Group
RDN
$5.22B
| $7.8M | 0.62% |
+670,943
| New | +$8.11M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Marshall Wace North America, which disclosed 422 positions worth $1.27B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Eli Lilly: 347,198 shares worth $17.1M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Consumer Discretionary and Technology.
- Marshall Wace North America's largest Q2 2013 buy was Eli Lilly: 347,198 shares worth $17.1M.
- Marshall Wace North America's ten largest holdings make up 12% of its $1.27B portfolio in Q2 2013.
- Marshall Wace North America disclosed 422 positions in Q2 2013, its first 13F filing on record.
Based on Marshall Wace North America's 13F filing for Q2 2013, filed 6 Aug 2013.